NephroPlus secures an investment of Rs. 850 crores from Quadria Capital (Quadria), a healthcare-focused private equity firm. Through this transaction, Quadria will acquire a significant minority stake through a combination of a primary investment and the purchase of shares from existing shareholders. The transaction will support NephroPlus in serving the growing demand for high quality, affordable dialysis services across India and other markets in Asia, says the company.
A company press release states that demand for dialysis services in the company’s target markets is expected to grow at a rate of over 11% annually over the next five years. Specialised chains are expected to gain market share as hospitals increasingly outsource dialysis operations and as governments seek to make high-quality dialysis services more accessible.
Vikram Vuppala, Founder and CEO of NephroPlus, said: “We look forward to expanding in India, while exploring further opportunities to bring our expertise and to more patients in other global markets.”
Sunil Thakur, Partner and Head of South Asia at Quadria Capital, said: “Quadria’s investment in NephroPlus underscores our ambition to invest in regional champions of Asian healthcare, who are providing high-quality, affordable healthcare to large, under-served populations.”